The recent advancements in TIM-3 Alzheimer’s treatment present a promising frontier in Alzheimer's therapy that leverages the immune system's inherent functions.Researchers have uncovered how the inhibition of TIM-3, an immune checkpoint molecule, empowers microglia to effectively combat the accumulation of amyloid plaques in the brain.